Cargando…

Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat

BACKGROUND: This experimental study was designed as a preclinical study for testing the hypothesis that intrarenal arterial (IRA) transfusion of human umbilical cord-derived mesenchymal stem cells (HUCDMSCs) therapy preserved the residual renal function of diabetic kidney disease (DKD) in rat [induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Ya, Yeh, Jui-Ning, Chiang, John Y., Sung, Pei-Hsun, Chen, Yi-Ling, Liu, Fanna, Yip, Hon-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080206/
https://www.ncbi.nlm.nih.gov/pubmed/35526048
http://dx.doi.org/10.1186/s13287-022-02857-5
_version_ 1784702731268653056
author Yue, Ya
Yeh, Jui-Ning
Chiang, John Y.
Sung, Pei-Hsun
Chen, Yi-Ling
Liu, Fanna
Yip, Hon-Kan
author_facet Yue, Ya
Yeh, Jui-Ning
Chiang, John Y.
Sung, Pei-Hsun
Chen, Yi-Ling
Liu, Fanna
Yip, Hon-Kan
author_sort Yue, Ya
collection PubMed
description BACKGROUND: This experimental study was designed as a preclinical study for testing the hypothesis that intrarenal arterial (IRA) transfusion of human umbilical cord-derived mesenchymal stem cells (HUCDMSCs) therapy preserved the residual renal function of diabetic kidney disease (DKD) in rat [induction by 5/6 nephrectomy of left kidney and right nephrectomy, followed by intraperitoneal administration of aminoguanidine (180 mg/kg) and streptozotocin (30 mg/kg)]. METHODS: Animals (n = 24) were categorized into group 1 (sham-operated control), group 2 (DKD), group 3 [DKD + HUCDMSCs (2.1 × 10(5)/IRA injection at day 28 after CKD induction)] and group 4 [(DKD + HUCDMSCs (6.3 × 10(5)/IRA injection)]. RESULTS: By day 60 after DKD induction, the kidneys were harvested and the result showed that the creatinine level, ratio of urine protein/urine creatinine and kidney injury score were lowest in group 1, highest in group 2 and significantly lower in group 4 than in group 3 (all p < 0.0001). The protein expressions of apoptotic (cleaved caspase-3/cleaved PARP/mitochondrial Bax), fibrotic (TGF-ß/p-Smad3), autophagic (ratio of LC3B-II/LC3B-I, Atg5/Beclin-1), oxidative stress (NOX-1/NOX-2/oxidized protein/p22phox), mitochondrial/DNA-damaged (cytosolic-cytochrome-C/DRP1/γ-H2AX) and inflammatory (MMP-9/TNF-α/p-NF-κB) biomarkers exhibited an identical pattern, whereas the protein expressions of angiogenesis factors (CD31/vWF/vascularity) exhibited an opposite pattern of creatinine level among the groups (all p < 0.0001). Histopathological findings demonstrated the renal tubular-damaged (KIM-1)/kidney fibrosis area/oxidative stress (8-OHdG + cells) expressed an identical pattern, whereas the podocyte components (ZO-1/synaptopodin/podocin) exhibited an opposite pattern of creatinine level among the groups (all p < 0.0001). No tumorigenesis or immune rejection event was identified. CONCLUSION: IRA injection of xenogeneic MSCs was safe and effectively protected the residual renal function and architectural integrity in DKD rat.
format Online
Article
Text
id pubmed-9080206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90802062022-05-09 Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat Yue, Ya Yeh, Jui-Ning Chiang, John Y. Sung, Pei-Hsun Chen, Yi-Ling Liu, Fanna Yip, Hon-Kan Stem Cell Res Ther Research BACKGROUND: This experimental study was designed as a preclinical study for testing the hypothesis that intrarenal arterial (IRA) transfusion of human umbilical cord-derived mesenchymal stem cells (HUCDMSCs) therapy preserved the residual renal function of diabetic kidney disease (DKD) in rat [induction by 5/6 nephrectomy of left kidney and right nephrectomy, followed by intraperitoneal administration of aminoguanidine (180 mg/kg) and streptozotocin (30 mg/kg)]. METHODS: Animals (n = 24) were categorized into group 1 (sham-operated control), group 2 (DKD), group 3 [DKD + HUCDMSCs (2.1 × 10(5)/IRA injection at day 28 after CKD induction)] and group 4 [(DKD + HUCDMSCs (6.3 × 10(5)/IRA injection)]. RESULTS: By day 60 after DKD induction, the kidneys were harvested and the result showed that the creatinine level, ratio of urine protein/urine creatinine and kidney injury score were lowest in group 1, highest in group 2 and significantly lower in group 4 than in group 3 (all p < 0.0001). The protein expressions of apoptotic (cleaved caspase-3/cleaved PARP/mitochondrial Bax), fibrotic (TGF-ß/p-Smad3), autophagic (ratio of LC3B-II/LC3B-I, Atg5/Beclin-1), oxidative stress (NOX-1/NOX-2/oxidized protein/p22phox), mitochondrial/DNA-damaged (cytosolic-cytochrome-C/DRP1/γ-H2AX) and inflammatory (MMP-9/TNF-α/p-NF-κB) biomarkers exhibited an identical pattern, whereas the protein expressions of angiogenesis factors (CD31/vWF/vascularity) exhibited an opposite pattern of creatinine level among the groups (all p < 0.0001). Histopathological findings demonstrated the renal tubular-damaged (KIM-1)/kidney fibrosis area/oxidative stress (8-OHdG + cells) expressed an identical pattern, whereas the podocyte components (ZO-1/synaptopodin/podocin) exhibited an opposite pattern of creatinine level among the groups (all p < 0.0001). No tumorigenesis or immune rejection event was identified. CONCLUSION: IRA injection of xenogeneic MSCs was safe and effectively protected the residual renal function and architectural integrity in DKD rat. BioMed Central 2022-05-07 /pmc/articles/PMC9080206/ /pubmed/35526048 http://dx.doi.org/10.1186/s13287-022-02857-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yue, Ya
Yeh, Jui-Ning
Chiang, John Y.
Sung, Pei-Hsun
Chen, Yi-Ling
Liu, Fanna
Yip, Hon-Kan
Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
title Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
title_full Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
title_fullStr Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
title_full_unstemmed Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
title_short Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
title_sort intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080206/
https://www.ncbi.nlm.nih.gov/pubmed/35526048
http://dx.doi.org/10.1186/s13287-022-02857-5
work_keys_str_mv AT yueya intrarenalarterialadministrationofhumanumbilicalcordderivedmesenchymalstemcellseffectivelypreservedtheresidualrenalfunctionofdiabetickidneydiseaseinrat
AT yehjuining intrarenalarterialadministrationofhumanumbilicalcordderivedmesenchymalstemcellseffectivelypreservedtheresidualrenalfunctionofdiabetickidneydiseaseinrat
AT chiangjohny intrarenalarterialadministrationofhumanumbilicalcordderivedmesenchymalstemcellseffectivelypreservedtheresidualrenalfunctionofdiabetickidneydiseaseinrat
AT sungpeihsun intrarenalarterialadministrationofhumanumbilicalcordderivedmesenchymalstemcellseffectivelypreservedtheresidualrenalfunctionofdiabetickidneydiseaseinrat
AT chenyiling intrarenalarterialadministrationofhumanumbilicalcordderivedmesenchymalstemcellseffectivelypreservedtheresidualrenalfunctionofdiabetickidneydiseaseinrat
AT liufanna intrarenalarterialadministrationofhumanumbilicalcordderivedmesenchymalstemcellseffectivelypreservedtheresidualrenalfunctionofdiabetickidneydiseaseinrat
AT yiphonkan intrarenalarterialadministrationofhumanumbilicalcordderivedmesenchymalstemcellseffectivelypreservedtheresidualrenalfunctionofdiabetickidneydiseaseinrat